Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer

European Journal of Surgical Oncology

Volumn 31, Issue 8, 2005, Pages 863-868

  Aguiar Jr , Samuel ^a   Lopes, A ^a   Soares, F A ^a   Rossi, B M ^a   Ferreira, F O ^a   Nakagawa, W T ^a   Carvalho, A L ^a   Filho, W J D ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

5 Fluorouracil; Chemotherapy, adjuvant; Colorectal neoplasms; Thymidylate synthase

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; LEVAMISOLE; THYMIDYLATE SYNTHASE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT OUTCOME;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; FORECASTING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYMIDYLATE SYNTHASE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 26444472368     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2005.03.014     Document Type: Article

References (27)

1. D.M. Parkin Global cancer statistics in the year 2000 Lancet Oncol 2 2001 596
2. American Cancer Society. Cancer facts and figures 2003. Available from URL: http://www.cancer.org [accessed August 12, 2003].
3. H. Nelson N. Petrelli A. Carlin J. Couture J. Fleshman J. Guillem et al. Guidelines 2000 for colon and rectal surgery J Natl Cancer Inst 93 2001 583-596
4. NIH Consensus Conference Adjuvant therapy for patients with colon and rectal cancer JAMA 264 1990 1444-1450
5. N. Kemeny L. Saltz A. Cohen Adjuvant therapy of colorectal cancer Surg Oncol Clin N Am 6 1997 699-723
6. P. Ragnhammar L. Halfström P. Nygrem B. Glimelius A systematic overview of chemotherapy effects in colorectal cancer Acta Oncol 40 2001 282-308
7. F.L. Greene D.L. Page I.D. Fleming A.G. Fritz C.M. Balch D.G. Haller et al. AJCC staging manual 6th ed 2002 Springer New York
8. H.M. Pinedo G.F.J. Peters Fluorouracil: Biochemistry and pharmacology J Clin Oncol 6 1988 1653-1664
9. R.B. Diasio B.E. Harris Clinical pharmacology of 5-fluorouracil Clin Pharmacokinet 16 1989 215-237
10. C.W. Carreras D.V. Santi The catalytic mechanism and structure of thymidylate synthase Ann Rev Biochem 64 1995 721-762
11. P.J. Johnston J.C. Drake J. Trepel C.J. Allegra Immunological quantitation of thymidylate synthase using monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines Cancer Res 52 1992 4306-4312
12. S. Copur K. Aiba J.C. Drake C.J. Allegra E. Chu Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil Biochem Pharmacol 49 1995 1419-1426
13. C.G. Leichman H.J. Lenz L. Leichman K.D. Danenberg J. Baranda S. Groshen et al. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin J Clin Oncol 15 1997 3223-3229
14. C. Aschele D. Debernardis S. Casaza G. Antonelli G. Tunesi C. Baldo et al. Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy J Clin Oncol 17 1999 1760-1770
15. P.G. Johnston E.R. Fisher H.E. Rockette B. Fisher N. Wolmark C.J. Drake et al. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer J Clin Oncol 12 1994 2640-2647
16. T. Yamachika H. Nakanishi K. Inada T. Tsukamoto T. Kato M. Fukushima et al. A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance Cancer 82 1998 70-77
17. T. Takenoue H. Nagawa K. Matsuda M. Fujii S. Fujii M.E. Nita et al. Relation between thymidylate synthase expression and survival in colon carcinoma, and determination of appropriate application of 5-fluorouracil by immunohistochemical method Ann Surg Oncol 7 2000 193-198
18. D. Edler B. Glimelius M. Hallström A. Jakobsen P.G. Johnston I. Magnusson et al. Thymidylate synthase expression in colorectal cancer: A prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy J Clin Oncol 20 2002 1721-1728
19. C.J. Allegra A.L. Parr L.E. Wold M.R. Mahoney D.L. Sargent P.G. Johnston et al. Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer J Clin Oncol 20 2002 1735-1743
20. S. Popat A. Matakidou R.S. Houlston Thymidylate synthase expression and prognosis in colorectal cancer: A systematic review and meta-analysis J Clin Oncol 22 2004 529-536
21. E. Chu D.M. Koeller J.L. Casey C.J. Drake A.B. Chabner P.C. Elwood et al. Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase Proc Natl Acad Sci USA 88 1991 8977-8981
22. B. Van Triest H.M. Pinedo J.L.G. Blaauwgeers P.J. van Diest P.S. Schoenmakers D.A. Voorn et al. Prognostic role of thymidylate synthase, thymidyne phosphorilase, platelet-derived endothelial cell growth factor, and proliferation marker in colorectal cancer Clin Cancer Res 6 2000 1063-1072
23. P.G. Johnston H.J. Lenz C.G. Leichman K.D. Danenberg C.J. Allegra P.V. Danenberg et al. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors Cancer Res 55 1995 1407-1412
24. A.L. Parr C.J. Drake R.E. Gress G. Schwartz S.M. Steinberg C.J. Allegra 5-Fluorouracil-mediated thymidylate synthase induction in malignant and nonmalignant human cells Biochem Pharmacol 56 1998 231-235
25. G.J. Peters B. van Triest H.H.J. Backus C.M. Kuiper C.L. van der Wilt H.M. Pinedo Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed Eur J Cancer 36 2000 916-924
26. G.J. Peters H.H.J. Backus S. Freemantle G. van Triest G. Codacci-Pisanelli C.L. van der Wilt et al. Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism Biochem Biophys Acta 1587 2002 194-205
27. T. Andre C. Boni L. Mounedji-Boudiaf M. Navarro J. Tabernero T. Hickish et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2004 2343-2351